Sharon L. Ripp

1.8k citations

30 papers · 1.3k indexed · h-index 22

Pharmacology top 0.5%
Molecular Biology
Oncology top 10%
Endocrinology, Diabetes and Metabolism top 5%
Biochemistry top 5%

Co-authors: Russell A. Prough Adnan A. Elfarra Richard M. Philpot Odette A. Fahmi Kristy K. Michael Miller R. Scott Obach Kiyoshi Itagaki Lila H. Overby
Topics: Pharmacogenetics and Drug Metabolism (14 papers)Hormonal and reproductive studies (7 papers)Sulfur Compounds in Biology (6 papers)
Cited by: Pharmacology Biochemistry Endocrinology, Diabetes and Metabolism
Journals: Journal of Medicinal Chemistry Archives of Biochemistry and Biophysics Molecular Pharmacology
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Sharon L. Ripp

30 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sharon L. Ripp

Since Specialization

Citations

This map shows the geographic impact of Sharon L. Ripp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon L. Ripp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon L. Ripp more than expected).

Fields of papers citing papers by Sharon L. Ripp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon L. Ripp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon L. Ripp. The network helps show where Sharon L. Ripp may publish in the future.

Co-authorship network of co-authors of Sharon L. Ripp

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon L. Ripp. A scholar is included among the top collaborators of Sharon L. Ripp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon L. Ripp. Sharon L. Ripp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab 2020 ·Regulatory Toxicology and Pharmacology ·(unknown),Ahmed Shoieb,Sharon L. Ripp,Gregory L. Finch,(unknown),Shawn P. O’Neil,Zaher A. Radi,Jameel Syed,Matthew S. Thompson,Michael W. Leach	11
2	Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects 2013 ·Clinical Pharmacology in Drug Development ·Joan Korth‐Bradley,Virginia Parks,Frank Wagner,Stephan Chalon,Ian Gourley,Kyle Matschke,(unknown),Sharon L. Ripp,Lawrence Fleckenstein	15
3	Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: A combination study design in support of a Paediatric Investigation Plan 2012 ·Regulatory Toxicology and Pharmacology ·David M. Cross,Gary W. Chmielewski,Elise Lewis,Lei Liu,(unknown),Sharon L. Ripp,(unknown),Christopher Bowman	3
4	DHEA metabolites activate estrogen receptors alpha and beta 2012 ·Steroids ·Kristy K. Michael Miller,(unknown),Margarita M. Ivanova,Kathleen A. Mattingly,Sharon L. Ripp,Carolyn M. Klinge,Russell A. Prough	64
5	Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks 2012 ·Journal of Medicinal Chemistry ·Suvi T. M. Orr,Sharon L. Ripp,T. Eric Ballard,Jaclyn L. Henderson,Dennis O. Scott,R. Scott Obach,Hao Sun,Amit S. Kalgutkar	162
6	Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges 2011 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·Christopher Bowman,Gary W. Chmielewski,Elise Lewis,Sharon L. Ripp,(unknown),David M. Cross	6
7	Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs 2011 ·Drug Metabolism and Disposition ·Raman Sharma,Timothy J. Strelevitz,Hongying Gao,(unknown),Klaas Schildknegt,R. Scott Obach,Sharon L. Ripp,Douglas K. Spracklin,Larry M. Tremaine,Alfin D. N. Vaz	81
8	Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),William H. Brissette,Matthew F. Brown,Jeffrey Casavant,Jonathan L. Doty,James P. Driscoll,Thomas M. Harris,Christopher S. Jones,Sandra P. McCurdy,Eric B. McElroy,Mark J. Mitton‐Fry,Michael J. Munchhof,(unknown),Lawrence A. Reiter,Sharon L. Ripp,Andrei Shavnya,(unknown),(unknown)	7
9	Evaluation of models for predicting drug–drug interactions due to induction 2010 ·Expert Opinion on Drug Metabolism & Toxicology ·Odette A. Fahmi,Sharon L. Ripp	54
10	Modulation of Receptor Phosphorylation Contributes to Activation of Peroxisome Proliferator Activated Receptor α by Dehydroepiandrosterone and Other Peroxisome Proliferators 2007 ·Molecular Pharmacology ·Viola Tamási,Kristy K. Michael Miller,Sharon L. Ripp,(unknown),(unknown),Russell A. Prough	32
11	Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction 2006 ·Drug Metabolism and Disposition ·Sharon L. Ripp,(unknown),Odette A. Fahmi,(unknown),Jennifer L. Liras,Tristan S. Maurer,Sonia M. de Morais	79
12	TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS 2004 ·Drug Metabolism and Disposition ·David S. Riddick,Chunja Lee,Anahita Bhathena,Yoav Timsit,Po‐Yung Cheng,Edward T. Morgan,Russell A. Prough,Sharon L. Ripp,Kristy K. Michael Miller,(unknown),John Y.L. Chiang	79
13	Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11β-hydroxysteroid dehydrogenases? 2003 ·Archives of Biochemistry and Biophysics ·B. Robinzon,(unknown),Sharon L. Ripp,Stephen J. Winters,Russell A. Prough	65
14	Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene 2003 ·Molecular Pharmacology ·Sharon L. Ripp,K. Cameron Falkner,(unknown),Viola Tamási,Russell A. Prough	26
15	Dehydroepiandrosterone Affects the Expression of Multiple Genes in Rat Liver Including 11β-Hydroxysteroid Dehydrogenase Type 1: A cDNA Array Analysis 2003 ·Molecular Pharmacology ·Shi Gu,Sharon L. Ripp,Russell A. Prough,Thomas Geoghegan	30
16	Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor 2002 ·Drug Metabolism and Disposition ·Sharon L. Ripp,Jennifer Fitzpatrick,Jeffrey M. Peters,Russell A. Prough	53
17	Metabolism of DHEA by Cytochromes P450 in Rat and Human Liver Microsomal Fractions 2001 ·Archives of Biochemistry and Biophysics ·Jennifer Fitzpatrick,Sharon L. Ripp,Ned B. Smith,William M. Pierce,Russell A. Prough	46
18	Methionine S-Oxidation in Human and Rabbit Liver Microsomes: Evidence for a High-Affinity Methionine S-Oxidase Activity That Is Distinct from Flavin-Containing Monooxygenase 3 1999 ·Archives of Biochemistry and Biophysics ·Sharon L. Ripp,Kiyoshi Itagaki,Richard M. Philpot,Adnan A. Elfarra	38
19	Species and Sex Differences in Expression of Flavin-Containing Monooxygenase Form 3 in Liver and Kidney Microsomes 1999 ·Drug Metabolism and Disposition ·Sharon L. Ripp,Kiyoshi Itagaki,Richard M. Philpot,Adnan A. Elfarra	66
20	Characterization of the MethionineS-Oxidase Activity of Rat Liver and Kidney Microsomes: Immunochemical and Kinetic Evidence for FMO3 Being the Major Catalyst 1996 ·Archives of Biochemistry and Biophysics ·Renee J. Krause,Sharon L. Ripp,Peter J. Sausen,Lila H. Overby,Richard M. Philpot,Adnan A. Elfarra	32

About Sharon L. Ripp

Sharon L. Ripp is a scholar working on Pharmacology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Hormonal and reproductive studies (7 papers) and Sulfur Compounds in Biology (6 papers). The work is most often cited by research in Pharmacology (569 citations), Biochemistry (146 citations) and Endocrinology, Diabetes and Metabolism (266 citations). Sharon L. Ripp has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Russell A. Prough, Adnan A. Elfarra, Richard M. Philpot, Odette A. Fahmi, Kristy K. Michael Miller, R. Scott Obach, Kiyoshi Itagaki, Lila H. Overby, Jennifer Fitzpatrick and Amit S. Kalgutkar. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact